| human | Q5 |
| P227 | GND ID | 1165683695 |
| P9843 | IRIS UNINA author ID | 29097 |
| P496 | ORCID iD | 0000-0002-8809-4931 |
| P11725 | PubliCatt author ID | 08809 |
| P1153 | Scopus author ID | 25636000100 |
| P214 | VIAF ID | 5517153596645751900008 |
| P10832 | WorldCat Entities ID | E39PBJg8FX6TXCRWd6bDcgbKh3 |
| P734 | family name | Muscogiuri | Q72712160 |
| Muscogiuri | Q72712160 | ||
| Muscogiuri | Q72712160 | ||
| P735 | given name | Giovanna | Q3806969 |
| Giovanna | Q3806969 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q36115742 | 25 Hydroxyvitamin D Deficiency and Its Relationship to Autoimmune Thyroid Disease in the Elderly |
| Q43164533 | 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity |
| Q92662143 | A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO) |
| Q103742417 | A practical nutritional guide for the management of sleep disturbances in menopause |
| Q33864198 | Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel Association |
| Q90232734 | Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS) |
| Q39215006 | Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance |
| Q61958111 | Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives |
| Q38659703 | Adrenocortical tumors and insulin resistance: What is the first step? |
| Q49380255 | Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes |
| Q60462116 | Albiglutide for the treatment of type 2 diabetes mellitus |
| Q52593350 | Association between Mediterranean diet and hand grip strength in older adult women. |
| Q48164630 | Association between vitamin D and sperm parameters: Clinical evidence |
| Q84500621 | Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes: comment to Kayaniyil et al |
| Q38029253 | Bariatric surgery and bone disease: from clinical perspective to molecular insights. |
| Q61855541 | Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity |
| Q90324886 | Bisphenol A: an emerging threat to female fertility |
| Q39197051 | Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus |
| Q90395670 | Breast cancer prevention in premenopausal women: role of the Mediterranean diet and its components |
| Q92964092 | Calcium and Vitamin D Supplementation. Myths and Realities with Regard to Cardiovascular Risk |
| Q37977731 | Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives |
| Q97884553 | Cardiovascular effects of antiobesity drugs: are the new medicines all the same? |
| Q41173285 | Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D? |
| Q94591394 | Chronotype and Adherence to the Mediterranean Diet in Obesity: Results from the Opera Prevention Project |
| Q59238017 | Coffee consumption, metabolic syndrome and clinical severity of psoriasis: good or bad stuff? |
| Q37575350 | Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney |
| Q64887622 | Comment on Krul-Poel et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes Care 2015;38:1420-1426. |
| Q91375639 | Correction to: Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives |
| Q46307017 | Could hop-derived bitter compounds improve glucose homeostasis by stimulating the secretion of GLP-1? |
| Q104067350 | Could ketogenic diet "starve" cancer? Emerging evidence |
| Q87029900 | Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept |
| Q35603166 | Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome |
| Q38832585 | Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside |
| Q40193299 | DYSREGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS INCREASES CENTRAL BODY FAT ACCUMULATION IN MALES AFFECTED BY DIABETES MELLITUS AND LATE-ONSET HYPOGONADISM. |
| Q88628823 | Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any? |
| Q53741548 | Differences in vitamin D status might help explain the outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. |
| Q98564417 | Does Sars-Cov-2 threaten our dreams? Effect of quarantine on sleep quality and body mass index |
| Q39077798 | Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept |
| Q53704701 | Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial. |
| Q38152642 | Effects of physical exercise on the female reproductive system |
| Q26739971 | Endocrine Aspects of Environmental "Obesogen" Pollutants |
| Q53941832 | Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. |
| Q42401366 | Environment and Health: Not Only Cancer |
| Q95938274 | Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective |
| Q42349365 | Erratum to "Inositols in the Treatment of Insulin-Mediated Diseases" |
| Q85896027 | Erratum to: GLP-1: benefits beyond pancreas |
| Q58993955 | Expanded Criteria Donors in Kidney Transplantation: The Role of Older Donors in a Setting of Older Recipients |
| Q38365868 | Focus on vitamin D and the adrenal gland. |
| Q92164626 | From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course? |
| Q97884559 | From obesity through gut microbiota to cardiovascular diseases: a dangerous journey |
| Q38238288 | GLP-1: benefits beyond pancreas. |
| Q90776498 | Gender-related issues in the pharmacology of new anti-obesity drugs |
| Q37333578 | Genetic disruption of SOD1 gene causes glucose intolerance and impairs β-cell function |
| Q39015837 | Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes |
| Q37475875 | Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment |
| Q35720799 | Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation |
| Q95729362 | Gut microbiota: a new path to treat obesity |
| Q39021924 | Gut: A key player in the pathogenesis of type 2 diabetes? |
| Q35172679 | HCC development is associated to peripheral insulin resistance in a mouse model of NASH. |
| Q50449744 | Hepatic Insulin Resistance and Altered Gluconeogenic Pathway in Premature Baboons. |
| Q51281687 | Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation. |
| Q60640969 | High-Normal TSH Values in Obesity: Is It Insulin Resistance or Adipose Tissue's Guilt? |
| Q48121381 | High-normal TSH values in obesity: is it insulin resistance or adipose tissue's guilt? |
| Q52655502 | Hypokalemia: a clinical update. |
| Q52306004 | Hypovitaminosis D in adolescents living in the land of sun is correlated with incorrect life style: a survey study in Campania region. |
| Q60690807 | Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? |
| Q60923064 | Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness |
| Q38572291 | Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk [Review]. |
| Q102386962 | Improving sleep disturbances in obesity by nutritional strategies: review of current evidence and practical guide |
| Q60640974 | In anorexia nervosa, even a small increase in abdominal fat is responsible for the appearance of insulin resistance |
| Q28075627 | Influence of Bisphenol A on Type 2 Diabetes Mellitus |
| Q95323135 | Influence of the Mediterranean Diet on 25- Hydroxyvitamin D Levels in Adults |
| Q28077870 | Inositols in the Treatment of Insulin-Mediated Diseases |
| Q37597046 | Insulin resistance alters islet morphology in nondiabetic humans |
| Q53815795 | Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome. |
| Q101166589 | Introduction to Vitamin D: current evidence and future directions |
| Q92950921 | Irritable bowel syndrome: a new therapeutic target when treating obesity? |
| Q50088089 | Letter to the Editor: Genetics and Vitamin D Supplementation in Pregnancy |
| Q89094694 | Letter to the Editor: Vitamin D: A Wonder Drug for the Cure of Type 2 Diabetes? |
| Q38291715 | Lifestyle changes in the management of adulthood and childhood obesity |
| Q62219716 | Lifestyle changes in the management of adulthood and childhood obesity |
| Q61855538 | Lipid profile in nonobese pregnant women with polycystic ovary syndrome: A prospective controlled clinical study |
| Q47632942 | Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies |
| Q86370601 | Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome |
| Q44518670 | Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? |
| Q38512310 | MECHANISMS IN ENDOCRINOLOGY: Metabolic syndrome through the female life cycle. |
| Q97884556 | Maternal obesity: focus on offspring cardiometabolic outcomes |
| Q26738955 | Maternal vitamin D levels during pregnancy and neonatal health: evidence to date and clinical implications |
| Q38215736 | Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease |
| Q82810591 | Medical therapy of aortic aneurysms: a pathophysiology-based approach |
| Q37673248 | Mediterranean Diet and Phase Angle in a Sample of Adult Population: Results of a Pilot Study |
| Q93205013 | Mediterranean diet as medical prescription in menopausal women with obesity: a practical guide for nutritionists |
| Q38841422 | Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess |
| Q60640976 | Metabolic Syndrome in Transplant Patients: An Academic or a Health Burden? |
| Q93144345 | Metabolic complications and kidney transplantation: focus on glycaemia and dyslipidaemia |
| Q88166767 | New light on an old vitamin: The role of the sunshine vitamin D in chronic disease |
| Q97550350 | New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists |
| Q37999946 | New-onset diabetes after kidney transplantation: prevalence, risk factors, and management |
| Q38043070 | New-onset diabetes mellitus: predictive factors and impact on the outcome of patients undergoing liver transplantation |
| Q97884550 | Nutrigenetics-personalized nutrition in obesity and cardiovascular diseases |
| Q97637880 | Nutrition and immune system: from the Mediterranean diet to dietary supplementary through the microbiota |
| Q91863648 | Nutrition and neuroendocrine tumors: An update of the literature |
| Q40086170 | Nutrition, inflammation and liver-spleen axis. |
| Q91893790 | Nutritional recommendations for CoVID-19 quarantine |
| Q93046975 | Nutritional status and follicular-derived thyroid cancer: An update |
| Q92486039 | Nutritionist and obesity: brief overview on efficacy, safety, and drug interactions of the main weight-loss dietary supplements |
| Q57114105 | Obesity and breast cancer in premenopausal women: Current evidence and future perspectives |
| Q58594691 | Obesity and sleep disturbance: the chicken or the egg? |
| Q30248235 | Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome |
| Q94469425 | Obesity: The "Achilles heel" for COVID-19? |
| Q48034695 | Obesogenic endocrine disruptors and obesity: myths and truths |
| Q48224155 | Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial |
| Q90730255 | Pancreatic Neuroendocrine Neoplasms: Does Sex Matter? |
| Q91048787 | Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study |
| Q92290827 | Phase Angle: A Possible Biomarker to Quantify Inflammation in Subjects with Obesity and 25(OH)D Deficiency |
| Q97564865 | Phase Angle: Could Be an Easy Tool to Detect Low-Grade Systemic Inflammation in Adults Affected by Prader-Willi Syndrome? |
| Q52673053 | Phtalates: new cardiovascular health disruptors? |
| Q47140852 | Physiological serum 25-hydroxyvitamin D concentrations are associated with improved thyroid function-observations from a community-based program. |
| Q91840826 | Prader- Willi syndrome: An uptodate on endocrine and metabolic complications |
| Q60587249 | Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas |
| Q40426355 | Prevalence of polycystic ovary morphology in a region of South Italy |
| Q36868293 | Removal of duodenum elicits GLP-1 secretion |
| Q83801774 | Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study |
| Q61812169 | Role of Nutrition and Adherence to the Mediterranean Diet in the Multidisciplinary Approach of Hidradenitis Suppurativa: Evaluation of Nutritional Status and Its Association with Severity of Disease |
| Q92011721 | Sex Differences of Vitamin D Status across BMI Classes: An Observational Prospective Cohort Study |
| Q39094823 | Shedding new light on female fertility: The role of vitamin D. |
| Q83836407 | Single-fiber conduction velocity test allows earlier detection of abnormalities in diabetes |
| Q92866163 | Sleep Apnea, Obesity, and Disturbed Glucose Homeostasis: Epidemiologic Evidence, Biologic Insights, and Therapeutic Strategies |
| Q94593211 | Sleep Quality in Obesity: Does Adherence to the Mediterranean Diet Matter? |
| Q97884566 | Sleep disturbances: one of the culprits of obesity-related cardiovascular risk? |
| Q90132849 | Somatotropic Axis and Obesity: Is There Any Role for the Mediterranean Diet? |
| Q90397890 | Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome |
| Q90713218 | Specific cut-off for the 25-OH vitamin D levels to predict the highest body mass index and fat mass: a sex prospective in patients with obesity |
| Q92124541 | The Sun's Vitamin in Adult Patients Affected by Prader-Willi Syndrome |
| Q54795646 | The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention. |
| Q38248109 | The good and bad effects of statins on insulin sensitivity and secretion |
| Q38496715 | The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes |
| Q91121626 | The lullaby of the sun: the role of vitamin D in sleep disturbance |
| Q47819836 | The management of neuroendocrine tumours: A nutritional viewpoint |
| Q91004865 | The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide |
| Q94653043 | The opera prevention project |
| Q37916647 | The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. |
| Q39283863 | The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? |
| Q92046452 | Trimethylamine N-oxide, Mediterranean diet, and nutrition in healthy, normal-weight adults: also a matter of sex? |
| Q60957234 | Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome |
| Q99618822 | Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists |
| Q55024741 | Vitamin D and Male Sexual Function: A Transversal and Longitudinal Study. |
| Q39064950 | Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke |
| Q30248959 | Vitamin D and chronic diseases: the current state of the art. |
| Q38794281 | Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer |
| Q93264181 | Vitamin D and psoriasis: an update for dermatologists and nutritionists |
| Q90194625 | Vitamin D and sleep regulation: is there a role for vitamin D? |
| Q38290687 | Vitamin D and thyroid disease: to D or not to D? |
| Q26864727 | Vitamin D deficiency: a new risk factor for type 2 diabetes? |
| Q59238013 | Water intake keeps type 2 diabetes away? Focus on copeptin |
| Q97884563 | What is the best diet for cardiovascular wellness? A comparison of different nutritional models |
| Q83136240 | Will vitamin D reduce insulin resistance? Still a long way to go |
| Q83716808 | β-Adrenergic Responsive Induction of Insulin Resistance in Liver of Aging Rats |
Search more.